
YALE JOURNAL OF BIOLOGY AND MEDICINE 87 (2014), pp.527-535.Copyright © 2014.
REVIEW
Renal Sympathetic Denervation in the Treatment of Resistant Hypertension
Catalina Sánchez-Álvarez, MDa; Miguel González-Vélez, MDa; ErikStilp, MDb; Charisse Ward, MD, MPHb; Carlos Mena-Hurtado, MD,FACC, FSCAIb*
a
CES University, Medellín, Colombia; bYale University, Department of Medicine, Section ofCardiology, New Haven, Connecticut
Arterial hypertension (HTN ) is a major health problem worldwide. Treatment-resistant hy-pertension (trHTN) is defined as the failure to achieve target blood pressure despite theconcomitant use of maximally tolerated doses of three different antihypertensive medica-tions, including a diuretic. trHTN is associated with considerable morbidity and mortality.Renal sympathetic denervation (RDn) is available and implemented abroad as a strategy forthe treatment of trHTN and is currently under clinical investigation in the United States. Se-lective renal sympathectomy via an endovascular approach effectively decreases renal sym-pathetic nerve hyperactivity leading to a decrease in blood pressure. The Symplicity catheter,currently under investigation in the United States, is a 6-French compatible system ad-vanced under fluoroscopic guidance via percutaneous access of the common femoral arteryto the distal lumen of each of the main renal arteries. Radiofrequency (RF) energy is thenapplied to the endoluminal surface of the renal arteries via an electrode located at the tip ofthe catheter. Two clinical trials (Symplicity HTN 1 and Symplicity HTN 2) have shown the ef-ficacy of RDn with a post-procedure decline of 27/17mmHg at 12 months and 32/12 mmHgat 6 months, respectively, with few minor adverse events. Symplicity HTN-3 study is a, multi-center, prospective, single-blind, randomized, controlled study currently under way and willprovide further insights about the safety and efficacy of renal denervation in patients withtrHTN.
Renal Sympathetic Denervation for Hypertension Symplicity HTN-2 研究 Renal Sympathetic Denervation For Treatment Of Resistant Hypertension: One Year Results From...
cacy of a multi-electrode renal sympathetic denervation system in resistant ...as a novel therapy for treatment of patients with drugresistant hypertension....
( 皖南医学院弋矶山医院心内科 皖南心血管研究所, 安徽 芜湖 241000) Renal Sympathetic Denervation for Treatment of Resistant Hypertension ZHOU Yu,CAO Heng (...
Abstract: Aims Catheter-based renal artery sympathetic denervation has emerged as a novel therapy for treatment of patients with drug resistant hypertension. ...
10047134DOC_1A 03/2012 Renal Sympathetic Denervation for Treatment of Resistant Hypertension: OneYear Results from the Symplicity HTN-2 Randomized Controlled ...
Renal Sympathetic Denervation In Resistant Hypertension: The SYMPLICITY Trial, ...the first worldwide online resource on treatment-resistant hypertension for phys...
新技术 Catheterbased renal sympathetic denervation for the treatment of refractory...renal sympathetic denervation for resistant hypertension: Durability of blood ...
and Treatment of High Blood Pressure. Hypertension, 2003, 120642: 1252. [...et al. Catheterbased renal sympathetic denervation for resistant hypertension: ...
Renal Nerve Ablation for Resistant Hypertension_临床医学_医药卫生_专业资料。Curr...Renal sympathetic denervation in patients with treatment-resistant hypertension ...
et al. Renal sympathetic denervation in patients with treatmentresistant hypertension...et al. Percutaneous renal denervation for the treatment of resistant essen...
热门文档